SI2563374T1 - Polietilenglikolni sestavki za nadzorovanje relapsa herpesa labialisa, herpesa genitalisa in herpesa zostra - Google Patents

Polietilenglikolni sestavki za nadzorovanje relapsa herpesa labialisa, herpesa genitalisa in herpesa zostra

Info

Publication number
SI2563374T1
SI2563374T1 SI201130086T SI201130086T SI2563374T1 SI 2563374 T1 SI2563374 T1 SI 2563374T1 SI 201130086 T SI201130086 T SI 201130086T SI 201130086 T SI201130086 T SI 201130086T SI 2563374 T1 SI2563374 T1 SI 2563374T1
Authority
SI
Slovenia
Prior art keywords
herpes
polyethylene glycol
genitalis
labialis
zoster
Prior art date
Application number
SI201130086T
Other languages
English (en)
Inventor
Peter Vitins
Marcel Langenauer
Paul Martin Scherer
Original Assignee
Devirex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex Ag filed Critical Devirex Ag
Publication of SI2563374T1 publication Critical patent/SI2563374T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201130086T 2010-07-08 2011-07-08 Polietilenglikolni sestavki za nadzorovanje relapsa herpesa labialisa, herpesa genitalisa in herpesa zostra SI2563374T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
EP11754919.6A EP2563374B1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (1)

Publication Number Publication Date
SI2563374T1 true SI2563374T1 (sl) 2014-01-31

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130086T SI2563374T1 (sl) 2010-07-08 2011-07-08 Polietilenglikolni sestavki za nadzorovanje relapsa herpesa labialisa, herpesa genitalisa in herpesa zostra

Country Status (21)

Country Link
US (2) US9814743B2 (sl)
EP (1) EP2563374B1 (sl)
JP (1) JP5858994B2 (sl)
KR (1) KR101881175B1 (sl)
CN (1) CN103079574B (sl)
AU (1) AU2011275458B2 (sl)
CA (1) CA2803228C (sl)
DK (1) DK2563374T3 (sl)
ES (1) ES2442928T3 (sl)
HK (1) HK1180969A1 (sl)
HR (1) HRP20140135T1 (sl)
IL (1) IL223582A (sl)
MX (1) MX2012014783A (sl)
PL (1) PL2563374T3 (sl)
PT (1) PT2563374E (sl)
RS (1) RS53162B (sl)
RU (1) RU2643763C2 (sl)
SG (1) SG186937A1 (sl)
SI (1) SI2563374T1 (sl)
WO (1) WO2012004669A1 (sl)
ZA (1) ZA201300177B (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG186937A1 (en) 2010-07-08 2013-02-28 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
CA2899424A1 (en) 2013-02-19 2014-08-28 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
ES2538335T3 (es) * 2013-05-14 2015-06-19 Najöpharm Gmbh I.G. Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
TW201825095A (zh) * 2016-11-28 2018-07-16 德商艾庫里斯抗感染治療有限公司 包含n-[5-(胺基磺醯基)-4-甲基-1,3-噻唑-2-基]-n-甲基-2-[4-(2-吡啶基)-苯基]-乙醯胺之局部醫藥調配物
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
WO2021233571A1 (de) * 2020-04-30 2021-11-25 Ninoderm Ug (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) * 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
JP2010516646A (ja) 2007-01-17 2010-05-20 デヴィレックス アーゲー シクロデキストリン処方物
SG186937A1 (en) 2010-07-08 2013-02-28 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Also Published As

Publication number Publication date
HRP20140135T1 (hr) 2014-03-28
PL2563374T3 (pl) 2014-04-30
ZA201300177B (en) 2014-03-26
EP2563374B1 (en) 2013-11-13
JP5858994B2 (ja) 2016-02-10
CN103079574A (zh) 2013-05-01
RU2643763C2 (ru) 2018-02-05
US20180055875A1 (en) 2018-03-01
SG186937A1 (en) 2013-02-28
JP2013530208A (ja) 2013-07-25
DK2563374T3 (da) 2014-01-20
RS53162B (en) 2014-06-30
KR20130142992A (ko) 2013-12-30
KR101881175B1 (ko) 2018-07-23
RU2013100383A (ru) 2014-08-20
WO2012004669A1 (en) 2012-01-12
CN103079574B (zh) 2017-04-12
EP2563374A1 (en) 2013-03-06
ES2442928T3 (es) 2014-02-14
CA2803228A1 (en) 2012-01-12
IL223582A (en) 2017-12-31
AU2011275458A1 (en) 2013-02-28
MX2012014783A (es) 2013-04-03
PT2563374E (pt) 2014-01-23
US9814743B2 (en) 2017-11-14
AU2011275458B2 (en) 2014-11-27
US20130090389A1 (en) 2013-04-11
CA2803228C (en) 2019-03-12
HK1180969A1 (en) 2013-11-01

Similar Documents

Publication Publication Date Title
HK1180969A1 (en) Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
IL245658A (en) Orcyl derivatives as axl and c – met kinase inhibitors
IL221823A (en) Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors
WO2011106105A9 (en) Inhibitors for antiviral use
EP2552208A4 (en) IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
HK1187905A1 (zh) 作為激酶抑制劑的取代的嘧啶基-吡咯類活性劑
ZA201204959B (en) Pyrazole derivatives as jak inhibitors
EP2706853A4 (en) AMINOPYRIMIDINE AS SYK-HEMMER
EP2552214A4 (en) PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
EP2632466A4 (en) QUINAZOLINE DERIVATIVES, COMPOSITIONS AND USES THEREOF
PL2627631T3 (pl) Pirrolidynony jako inhibitory metap2
EP2547334A4 (en) NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS
EP2694521A4 (en) PYRROLIDIN-CONDENSED THIADIAZINOXIDE COMPOUNDS AS BACE HEMMER, COMPOSITIONS AND THEIR USE
PL2606034T3 (pl) Pochodne pirymidynowe jako inhibitory fak
PL3070091T3 (pl) Pochodne benzodioksolu jako inhibitory fosfodiesterazy
ZA201406038B (en) Substituted pyrimidine compounds and their use as syk inhibitors
EP2916837A4 (en) BIPYRIDYLAMINOPYRIDINE PRODRUCE AS SYK INHIBITORS
EP2652055A4 (en) HYBRID ORGANIC INORGANIC COLOR COMPOSITION
GB201109094D0 (en) Indexable insert
SG10201706265PA (en) Novel compounds and compositions for targeting cancer stem cells
ZA201501812B (en) Nootropic compositions for improving memory performance
EP2907856A4 (en) AQUEOUS PRESERVATION COMPOSITION
HK1199024A1 (zh) 可作為 抑制物使用之新型嗎啉基衍生物
EP2760910A4 (en) OXETANE CONTAINING COMPOUNDS AND COMPOSITIONS BASED THEREON
EP2566484A4 (en) COMPOSITIONS WITH PURIN AND PYRIMIDIN NUCLEOSIDES, PEPTIDES AND MANGANESE AND ITS USES